Rapid & Short-Acting Insulin

A provider orders lispro with a meal tray arriving in 5 minutes and regular insulin for a blood glucose of 350. Timing each correctly prevents both hypoglycemia and hyperglycemic crisis.

Rapid-acting insulins (lispro, aspart, glulisine) onset in 10–15 minutes, peak at 1–2 hours, and last 3–5 hours. They are given immediately before or within 15 minutes of eating — if the meal is delayed, the dose is delayed, or the client risks hypoglycemia before food absorbs. Short-acting insulin (regular/Humulin R) has a slower profile: onset 30–60 minutes, peak 2–4 hours, duration 6–8 hours, so it is administered 30 minutes before meals. Regular insulin is the only insulin approved for IV use, making it the go-to for DKA, hyperkalemia, and sliding-scale correction in acute care. Both types cover postprandial (mealtime) glucose spikes, not basal needs — that territory belongs to intermediate and long-acting formulations. When mixing insulins in a syringe, always draw clear (regular) before cloudy (NPH) to prevent contaminating the regular vial with NPH particles. Rapid-acting analogs should never be mixed with long-acting insulins like glargine.

Key Distinctions

Don't confuse rapid-acting (lispro, aspart — onset 10–15 min) with short-acting (regular — onset 30–60 min); their meal-timing rules differ by 15+ minutes. Students often assume any insulin can go IV — only regular insulin is given intravenously. Remember that rapid-acting insulins peak earlier (1–2 hr), so hypoglycemia risk is closest to the meal, whereas regular insulin's later peak (2–4 hr) means monitor for lows between meals.

Clinical Pearl

"Clear before cloudy" keeps regular insulin pure. And if the meal tray hasn't arrived, rapid-acting insulin hasn't earned its injection yet — no food, no rapid dose.